Literature DB >> 10940346

The health benefits of wine.

J B German1, R L Walzem.   

Abstract

Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all-cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess. Researchers are working to explain this observation in molecular and nutritional terms. Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk. The question now is whether wine, particularly red wine with its abundant content of phenolic acids and polyphenols, confers additional health benefits. Discovering the nutritional properties of wine is a challenging task, which requires that the biological actions and bioavailability of the >200 individual phenolic compounds be documented and interpreted within the societal factors that stratify wine consumption and the myriad effects of alcohol alone. Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare. Thus, although the benefits of the polyphenols from fruits and vegetables are increasingly accepted, consensus on wine is developing more slowly. Scientific research has demonstrated that the molecules present in grapes and in wine alter cellular metabolism and signaling, which is consistent mechanistically with reducing arterial disease. Future research must address specific mechanisms both of alcohol and of polyphenolic action and develop biomarkers of their role in disease prevention in individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940346     DOI: 10.1146/annurev.nutr.20.1.561

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  61 in total

1.  Ochratoxin A-induced renal cortex fibrosis and epithelial-to-mesenchymal transition: molecular mechanisms of ochratoxin A-injury and potential effects of red wine.

Authors:  Nicoletta Gagliano; Carlo Torri; Elena Donetti; Fabio Grizzi; Francesco Costa; Alberto A E Bertelli; Massimiliano Migliori; Cristina Filippi; Marzia Bedoni; Vincenzo Panichi; Luca Giovannini; Magda Gioia
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

2.  Transcriptomic and metabolite analyses of Cabernet Sauvignon grape berry development.

Authors:  Laurent G Deluc; Jérôme Grimplet; Matthew D Wheatley; Richard L Tillett; David R Quilici; Craig Osborne; David A Schooley; Karen A Schlauch; John C Cushman; Grant R Cramer
Journal:  BMC Genomics       Date:  2007-11-22       Impact factor: 3.969

Review 3.  Resveratrol and the eye: activity and molecular mechanisms.

Authors:  Christina Bola; Hannah Bartlett; Frank Eperjesi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-21       Impact factor: 3.117

4.  Localization of the noncovalent binding site between amyloid-beta-peptide and oleuropein using electrospray ionization FT-ICR mass spectrometry.

Authors:  Fotini N Bazoti; Jonas Bergquist; Karin Markides; Anthony Tsarbopoulos
Journal:  J Am Soc Mass Spectrom       Date:  2008-04-08       Impact factor: 3.109

5.  Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS.

Authors:  Qun Wang; Albert Y Sun; Agnes Simonyi; Theodore J Kalogeris; Dennis K Miller; Grace Y Sun; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2007-07-04       Impact factor: 7.376

6.  Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds.

Authors:  Clara Lemos; Godefridus J Peters; Gerrit Jansen; Fátima Martel; Conceição Calhau
Journal:  Eur J Nutr       Date:  2007-08-21       Impact factor: 5.614

7.  Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Authors:  Lap Ho; Mario G Ferruzzi; Elsa M Janle; Jun Wang; Bing Gong; Tzu-Ying Chen; Jessica Lobo; Bruce Cooper; Qing Li Wu; Stephen T Talcott; Susan S Percival; James E Simon; Giulio Maria Pasinetti
Journal:  FASEB J       Date:  2012-10-24       Impact factor: 5.191

Review 8.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

10.  Resveratrol inhibits nicotinic stimulation-evoked catecholamine release from the adrenal medulla.

Authors:  Seong-Chang Woo; Gwang-Moon Na; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.